Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Anidulafungin × Clear all

Phase

Status

Sponsor Class

OTHER 2 NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neutropenia 1 Infections 1

Interventions

Cyclophosphamide 354 Specimen Handling 332 Magnetic Resonance Spectroscopy 289 Radiotherapy 279 Biopsy 243 Cisplatin 237 Carboplatin 225 Paclitaxel 202 Doxorubicin 201 Fluorouracil 181 Etoposide 181 Vincristine 171 Bevacizumab 169 Filgrastim 155 Gemcitabine 148 Leucovorin 134 Cytarabine 133 aldesleukin 128 Docetaxel 110 Taxes 104 fludarabine phosphate 101 Rituximab 101 Oxaliplatin 101 Chemotherapy, Adjuvant 101 Prednisone 94 Methotrexate 93 Irinotecan 93 Bortezomib 93 Radiation 92 Peripheral Blood Stem Cell Transplantation 89

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00068471 2013-06-19

Anidulafungin in Treating Immunocompromised Children With Neutropenia

National Cancer Institute (NCI)

Phase 1/2 Completed

Infections, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡